Draper Asset Management LLC Buys New Stake in LENSAR, Inc. (NASDAQ:LNSR)

Draper Asset Management LLC bought a new stake in shares of LENSAR, Inc. (NASDAQ:LNSR - Free Report) in the first quarter, according to its most recent disclosure with the Securities & Exchange Commission. The institutional investor bought 40,040 shares of the company's stock, valued at approximately $565,000. LENSAR comprises approximately 0.4% of Draper Asset Management LLC's holdings, making the stock its 14th largest position. Draper Asset Management LLC owned about 0.34% of LENSAR at the end of the most recent quarter.

A number of other hedge funds and other institutional investors have also added to or reduced their stakes in LNSR. Huntleigh Advisors Inc. purchased a new stake in shares of LENSAR in the first quarter worth $1,069,000. Brandes Investment Partners LP increased its stake in shares of LENSAR by 10.4% in the fourth quarter. Brandes Investment Partners LP now owns 489,318 shares of the company's stock worth $4,375,000 after purchasing an additional 45,920 shares in the last quarter. Renaissance Technologies LLC increased its stake in shares of LENSAR by 13.3% in the fourth quarter. Renaissance Technologies LLC now owns 348,891 shares of the company's stock worth $3,119,000 after purchasing an additional 40,946 shares in the last quarter. Atria Investments Inc increased its stake in shares of LENSAR by 28.2% in the fourth quarter. Atria Investments Inc now owns 26,055 shares of the company's stock worth $233,000 after purchasing an additional 5,729 shares in the last quarter. Finally, Geode Capital Management LLC increased its stake in shares of LENSAR by 5.6% in the fourth quarter. Geode Capital Management LLC now owns 106,058 shares of the company's stock worth $948,000 after purchasing an additional 5,627 shares in the last quarter. 40.15% of the stock is owned by hedge funds and other institutional investors.

Analyst Upgrades and Downgrades

A number of brokerages have recently issued reports on LNSR. BTIG Research cut shares of LENSAR from a "strong-buy" rating to a "hold" rating in a research note on Monday, March 24th. Lake Street Capital reissued a "hold" rating and issued a $15.00 price objective (down from $16.00) on shares of LENSAR in a research note on Monday, March 24th.

LENSAR Trading Down 1.0%

LNSR traded down $0.13 during trading on Monday, hitting $12.90. 82,382 shares of the company traded hands, compared to its average volume of 93,125. The company has a market cap of $152.09 million, a PE ratio of -2.66 and a beta of 0.50. The stock's 50-day simple moving average is $13.24 and its two-hundred day simple moving average is $12.43. LENSAR, Inc. has a 1 year low of $3.50 and a 1 year high of $17.31.

LENSAR (NASDAQ:LNSR - Get Free Report) last posted its earnings results on Thursday, May 8th. The company reported ($2.32) earnings per share for the quarter, missing the consensus estimate of ($0.16) by ($2.16). The company had revenue of $11.53 million for the quarter, compared to analysts' expectations of $13.40 million. LENSAR had a negative net margin of 99.17% and a negative return on equity of 737.30%.

LENSAR Profile

LENSAR, Inc, a commercial-stage medical device company, focuses on designing, developing, and marketing a femtosecond laser system for the treatment of cataracts and the management of pre-existing or surgically induced corneal astigmatism. It offers LENSAR Laser System that incorporates a range of proprietary technologies designed to assist the surgeon in obtaining visual outcomes, efficiency, and reproducibility by providing imaging, procedure planning, design, and precision.